EY's former global health leader Jacques Mulder joins A&M

Jacques Mulder, the former global leader of EY’s Healthcare practice, has joined Alvarez & Marsal as a managing director. He will be based in Miami. 

Mulder brings more than 25 years of consulting and industry experience to the role. Most recently, he was a president at Ciox Health, a healthcare information management company based in Georgia. Before that, Mulder was the global and US leader of EY’s healthcare practice, responsible for leading the firm’s advisory offerings including strategy, mergers & acquisitions, performance improvement, operational excellence, and digital transformation. 

Prior to joining EY, he spent a decade at rival Big Four accounting and consulting firm Deloitte Consulting, where he established, developed and built the firm's life sciences practice and latterly served as chief strategy officer for the life sciences & healthcare industry vertical, leading the development and execution of Deloitte’s domestic strategy for the sector. 

During his tenure at EY and Deloitte, Mulder advised clients on transformation initiatives in sales and marketing, research and development, launches of new products and services, and the development of strategic alliances and partnerships. He also advised clients on diligence efforts for strategic investment and product acquisitions, and on large merger integration processes.

Earlier in his career, he worked for, among others, Quintiles (now IQVIA), The Lewin Group (now a subsidiary of Optum), and for Abbott Laboratories and GlaxoSmithKline in Sub-Saharan Africa. 

At Alvarez & Marsal (A&M), one of the globe’s larger management consulting firms, Mulder will join the healthcare industry group, and will focus on the pharmaceutical and medtech sectors. He will leverage his deep expertise and knowledge in the field to help the firm’s clients with strategic transformations, business improvement, and innovation. 

Martin McGahan, head of Alvarez & Marsal’s healthcare practice, said, “Jacques’ in-depth sector knowledge and experience significantly boost A&M’s capabilities to offer integrated solutions that maximize value and drive long-term results for the pharmaceutical and device industries. He will help our clients meet critical market demand,” he said, referring to the spike in demand for pharma products amid the current Covid-19 pandemic.

Jacques Mulder holds a bachelor’s degree in physiology and biomechanics from Clemson University and an MBA (with specialization in finance and competitive strategy) from the Edinburgh Business School in Scotland.